Gabapentin
Gabapentin is a prescription medication used to treat seizures and nerve pain by reducing abnormal electrical activity in the brain. Available as 600 mg and 800 mg oral tablets, it's a generic version manufactured by Aurobindo Pharma Limited under FDA application ANDA200651. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Gabapentin is a prescription medication used to treat seizures and nerve pain by reducing abnormal electrical activity in the brain. Available as 600 mg and 800 mg oral tablets, it's a generic version manufactured by Aurobindo Pharma Limited under FDA application ANDA200651. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Gabapentin", "mediaType": "text/html", "description": " Access the FDA dataset for Gabapentin — ANDA 077661 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077661" } ] |
| identifier | ANDA077661 |
| issued | 2016-09-16 |
| keyword |
[ "drug-manufacturers", "drug-safety", "fda", "prescription-drugs", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Gabapentin |
